Fierce Biotech News & Reports
WEB3 days ago — Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
AstraZeneca's '2.0' cancer pipeline built on bispecifics - Fierce …
WEBOct 24, 2023 — ESMO: AstraZeneca aims for '2.0' cancer pipeline, shares bispecific data. AstraZeneca, home of cancer blockbusters like Tagrisso and Daiichi Sankyo-partnered Enhertu, wants to elevate its cancer ...
MedTech | Fierce Biotech
WEB3 days ago — Pi-Cardia’s ShortCut device received a de novo clearance to open up old heart valve implants and clear the blood flow into the coronary arteries. Conor Hale Oct 1, 2024 2:00pm. Connect.
Biotech | Fierce Biotech
WEBAs always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team and let us know. Gabrielle Masson , Darren Incorvaia , Max Bayer Sep 30, 2024 10 ...
Pharma - Fierce Biotech
WEB4 days ago — Gritstone bio brought in bankers after its phase 2 colorectal cancer vaccine data fell short of the runaway success needed to transform its fortunes. Nick Paul Taylor Oct 1, 2024 10:07am. Connect ...
FDA clears Healthy.io’s smartphone-based kidney test - Fierce …
WEBJul 12, 2022 — According to Healthy.io, the Minuteful Kidney test marks the first smartphone-based, at-home ACR test cleared by the FDA. It was given the OK to run on all current Android and Apple smartphones ...
Viome scores FDA breakthrough label for cancer-screening, …
WEBMay 7, 2021 — RELATED: How the gut microbiome is inspiring new approaches to treating brain disorders As a result of that and other ongoing research, Viome’s saliva test has received the FDA’s breakthrough ...
The top biotech hubs in 2022 - Fierce Biotech
WEBBoston, unsurprisingly, remains the leading city for biotech startups and activity, with 135 tenants seeking space and more than 13.6 million square feet under construction. Other top cities for ...
Robert Lefkowitz to lead Septerna's $100M GPCR research - Fierce …
WEBJan 27, 2022 — Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder. Septerna wants to spark a second golden age in G-protein-coupled receptor drug ...
Pfizer revamps oncology R&D strategy - Fierce Biotech
WEBBy Gabrielle Masson Feb 29, 2024 6:03pm. Pfizer Oncology Seagen R&D. After investing heavily in COVID-19 over the last few years, Pfizer is pivoting to zoom in on cancer, with a laser focus on ...